Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “nOH”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Testing effectiveness (Phase 2)UnknownNCT00758849
What this trial is testing

Fipamezole in Neurogenic Orthostatic Hypotension

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Parkinson's DiseaseMultiple System Atrophy
Juvantia Pharma Ltd 24
Not applicableLooking for participantsNCT05908760
What this trial is testing

CO2 Rebreathing in nOH: A Proof-of-Concept Pilot Study

Who this might be right for
Neurogenic Orthostatic HypotensionAutonomic Failure
University of Calgary 28
Testing effectiveness (Phase 2)Study completedNCT02705755
What this trial is testing

TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)

Who this might be right for
Neurogenic Orthostatic HypotensionMultiple System Atrophy (MSA) With Orthostatic HypotensionPure Autonomic Failure+5 more
Theravance Biopharma 34
Testing effectiveness (Phase 2)UnknownNCT03567447
What this trial is testing

Effect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Parkinson DiseaseFalls Patient
St. Joseph's Hospital and Medical Center, Phoenix 10
Large-scale testing (Phase 3)Study completedNCT00738062
What this trial is testing

Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Neurogenic Orthostatic HypotensionNon-Diabetic Autonomic NeuropathyMultiple System Atrophy+1 more
Chelsea Therapeutics 103
Large-scale testing (Phase 3)Ended earlyNCT04095793
What this trial is testing

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 110
Large-scale testing (Phase 3)Ended earlyNCT03829657
What this trial is testing

Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSAParkinson's Disease (PD)+1 more
Theravance Biopharma 203
Early research (Phase 1)Study completedNCT04200573
What this trial is testing

Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855

Who this might be right for
Symptomatic Neurogenic Orthostatic HypertensionnOH
Theravance Biopharma 31
Not applicableNot Yet RecruitingNCT06751888
What this trial is testing

Controlled CO2 Inhalation in NOH

Who this might be right for
Neurogenic Orthostatic Hypotension
University of Calgary 28
Testing effectiveness (Phase 2)Ended earlyNCT00977171
What this trial is testing

Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome

Who this might be right for
Chronic Fatigue SyndromeOrthostatic HypotensionNeurally Mediated Hypotension+1 more
Chelsea Therapeutics 3
Large-scale testing (Phase 3)Study completedNCT00782340
What this trial is testing

A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic Failure+1 more
Chelsea Therapeutics 263
Large-scale testing (Phase 3)Study completedNCT03750552
What this trial is testing

Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 195
Large-scale testing (Phase 3)Study completedNCT01132326
What this trial is testing

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)

Who this might be right for
Primary Autonomic FailureDopamine Beta Hydroxylase DeficiencyNon-Diabetic Neuropathy+1 more
Chelsea Therapeutics 350
Large-scale testing (Phase 3)Study completedNCT01176240
What this trial is testing

A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease

Who this might be right for
Orthostatic HypotensionParkinson's Disease
Chelsea Therapeutics 225
Early research (Phase 1)Study completedNCT04688632
What this trial is testing

Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects

Who this might be right for
Symptomatic Neurogenic Orthostatic HypertensionnOH
Theravance Biopharma 72
Large-scale testing (Phase 3)Ended earlyNCT01927055
What this trial is testing

A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionParkinson's DiseaseMultiple Systems Atrophy+2 more
Chelsea Therapeutics 61
Large-scale testing (Phase 3)Study completedNCT00633880
What this trial is testing

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic Failure+1 more
Chelsea Therapeutics 181
Large-scale testing (Phase 3)Active Not RecruitingNCT05696717
What this trial is testing

Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSA - Multiple System Atrophy
Theravance Biopharma 102
Post-approval studies (Phase 4)Study completedNCT03229174
What this trial is testing

Brain Perfusion & Oxygenation in Parkinson's Disease With NOH

Who this might be right for
Parkinson DiseaseNeurogenic Orthostatic Hypotension
William Ondo, MD 17